ArticleFrontiers in cardiovascular medicine2024

Sacubitril/valsartan attenuates atrial conduction disturbance and electrophysiological heterogeneity with ameliorating fibrosis in mice.

Satoshi Iwamiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.